Business & Economy
Stay informed on the latest news, stories, and analysis of the local business and economy in Oxford and Oxfordshire, including economic trends, key company appointments, and developments of local enterprises.
-
Immunocore closes $75m Series C private financing round
Led by an existing investor, the funding follows positive Phase 3 trial interim analysis data for tebentafusp in patients with metastatic uveal melanoma.
-
Enara Bio enters strategic collaboration with Boehringer Ingelheim
The strategic collaboration and licensing agreement will research and develop novel targeted cancer immunotherapies, leveraging Enara Bio’s Dark Antigen™ discovery platform.
-
Oxford-based biotech Theolytics raises $6.8m Series A round funding
The round was co-led by Epidarex Capital and Taiho Ventures LLC with participation from existing investor, Oxford Sciences Innovation (OSI).
-
PerkinElmer to acquire Abingdon-based Oxford Immunotec
Under the terms of the Acquisition, Oxford Immunotec shareholders will be entitled to receive $22.00 in cash for each outstanding ordinary share.
-
Owen Mumford chosen as sole supplier for safety pen needles in Wales
Ateria® SafeControl® safety pen needles will now be used in all NHS Wales hospital environments, as well as by community nurses who also have access to the new procurement framework.
-
Grundon strengthens Board of Directors with two new appointments
Simon Arnold has been appointed Finance Director, whilst Jonathan Harris takes over as Technical Director of Wallingford-based Grundon Waste Management.
-
Biotech start-up DJS Antibodies raises £6m in seed funding
The biotech start-up company based in Upper Heyford will use the funds to accelerate the development of its novel antibody therapeutics for inflammatory disease.
-
Oxford-based Speik acquired by Dubber for £21.5 million
Speik, a leading UK-based provider of call recording and PCI (Payment Card Industry) compliance was acquired by Australia-based Dubber Corporation (Dubber), for £21.5 million.
-
Sensyne Health launches diabetes monitoring product in US
The solution will be offered to US health systems and health plans through Cognizant, their US sales and marketing partner.
-
Oxford BioDynamics appoints non-executive chairman
The biotechnology company developing personalised medicine tests based on 3D genomic biomarkers, has announced that Matthew Wakefield as its Non-Executive Chairman.
-
Therapeutics company PepGen raises $45m Series A funding
The funding round was led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor, University of Oxford and CureDuchenne.
-
Oxford-based AI company Sensyne Health raises £25m to fund growth
The funds will enable the company to capitalise on an expanding number of commercial opportunities, deliver economies of scale and accelerate future revenue growth.
-
Oxford Brookes Uni spinout MetaGuideX wins business innovation programme
The innovative cancer diagnostics company was identified from eight start-ups as a promising solution to the NHS and UK life science’s needs.
-
Oxford Metrics announces preliminary results to 30 Sept 2020
Headline revenue was £30.3m, down 14.3% on the previous year as pandemic has caused short-term sales delays, particularly in the USA.
-
Temps can help fuel Oxfordshire’s post COVID-19 economic recovery
Historically, it may have been difficult to find the right people for temporary roles at senior levels. However, the employment market has been upended.
-
Chevron Traffic Management completes company reorganisation
Chevron Traffic Management Ltd has completed a group reorganisation with recently acquired businesses merging to form a single harmonised traffic management business.